|
1
|
Collins AJ, Foley RN, Chavers B,
Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St
Peter W, et al: United States Renal Data System 2011 Annual Data
Report: Atlas of chronic kidney disease & end-stage renal
disease in the United States. Am J Kidney Dis. 59(Suppl 1):
e1–e420. 2012.
|
|
2
|
Hovind P, Rossing P, Tarnow L, Smidt UM
and Parving HH: Progression of diabetic nephropathy. Kidney Int.
59:702–709. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parving HH: Diabetic nephropathy:
Prevention and treatment. Kidney Int. 60:2041–2055. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanwar YS, Wada J, Sun L, Xie P, Wallner
EI, Chen S, Chugh S and Danesh FR: Diabetic nephropathy: Mechanisms
of renal disease progression. Exp Biol Med (Maywood). 233:4–11.
2008. View Article : Google Scholar
|
|
5
|
Ban CR and Twigg SM: Fibrosis in diabetes
complications: Pathogenic mechanisms and circulating and urinary
markers. Vasc Health Risk Manag. 4:575–596. 2008.PubMed/NCBI
|
|
6
|
Wiggins RC: The spectrum of
podocytopathies: A unifying view of glomerular diseases. Kidney
Int. 71:1205–1214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Drummond K and Mauer M; International
Diabetic Nephropathy Study Group: The early natural history of
nephropathy in type 1 diabetes: II. Early renal structural changes
in type 1 diabetes. Diabetes. 51:1580–1587. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pagtalunan ME, Miller PL, Jumping-Eagle S,
Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L and Meyer TW:
Podocyte loss and progressive glomerular injury in type II
diabetes. J Clin Invest. 99:342–348. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schiffer M, Bitzer M, Roberts IS, Kopp JB,
ten Dijke P, Mundel P and Böttinger EP: Apoptosis in podocytes
induced by TGF-beta and Smad7. J Clin Invest. 108:807–816. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Susztak K, Raff AC, Schiffer M and
Böttinger EP: Glucose-induced reactive oxygen species cause
apoptosis of podocytes and podocyte depletion at the onset of
diabetic nephropathy. Diabetes. 55:225–233. 2006. View Article : Google Scholar
|
|
11
|
Venkatachalam K and Montell C: TRP
channels. Annu Rev Biochem. 76:387–417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Montell C: The TRP superfamily of cation
channels. Sci STKE. 2005:re32005.PubMed/NCBI
|
|
13
|
Ramsey IS, Delling M and Clapham DE: An
introduction to TRP channels. Annu Rev Physiol. 68:619–647. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Winn MP, Conlon PJ, Lynn KL, Farrington
MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S,
Burchette JL, et al: A mutation in the TRPC6 cation channel causes
familial focal segmental glomerulosclerosis. Science.
308:1801–1804. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dryer SE and Reiser J: TRPC6 channels and
their binding partners in podocytes: Role in glomerular filtration
and pathophysiology. Am J Physiol Renal Physiol. 299:F689–F701.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Möller CC, Wei C, Altintas MM, Li J, Greka
A, Ohse T, Pippin JW, Rastaldi MP, Wawersik S, Schiavi S, et al:
Induction of TRPC6 channel in acquired forms of proteinuric kidney
disease. J Am Soc Nephrol. 18:29–36. 2007. View Article : Google Scholar
|
|
17
|
Yang H, Zhao B, Liao C, Zhang R, Meng K,
Xu J and Jiao J: High glucose-induced apoptosis in cultured
podocytes involves TRPC6-dependent calcium entry via the RhoA/ROCK
pathway. Biochem Biophys Res Commun. 434:394–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Z, Xu J, Xu P, Liu S and Yang Z:
Wnt/β-catenin signalling pathway mediates high glucose induced cell
injury through activation of TRPC6 in podocytes. Cell Prolif.
46:76–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu BC, Song X, Lu XY, Li DT, Eaton DC,
Shen BZ, Li XQ and Ma P: High glucose induces podocyte apoptosis by
stimulating TRPC6 via elevation of reactive oxygen species. Biochim
Biophys Acta. 1833:1434–1442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kuwahara K, Wang Y, McAnally J, Richardson
JA, Bassel-Duby R, Hill JA and Olson EN: TRPC6 fulfills a
calcineurin signaling circuit during pathologic cardiac remodeling.
J Clin Invest. 116:3114–3126. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishida M, Onohara N, Sato Y, Suda R,
Ogushi M, Tanabe S, Inoue R, Mori Y and Kurose H:
Galpha12/13-mediated up-regulation of TRPC6 negatively regulates
endothelin-1-induced cardiac myofibroblast formation and collagen
synthesis through nuclear factor of activated T cells activation. J
Biol Chem. 282:23117–23128. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Onohara N, Nishida M, Inoue R, Kobayashi
H, Sumimoto H, Sato Y, Mori Y, Nagao T and Kurose H: TRPC3 and
TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
EMBO J. 25:5305–5316. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia Y, Zhou J, Tai Y and Wang Y: TRPC
channels promote cerebellar granule neuron survival. Nat Neurosci.
10:559–567. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rao A, Luo C and Hogan PG: Transcription
factors of the NFAT family: Regulation and function. Annu Rev
Immunol. 15:707–747. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Jarad G, Tripathi P, Pan M,
Cunningham J, Martin DR, Liapis H, Miner JH and Chen F: Activation
of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc
Nephrol. 21:1657–1666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Chang JH, Paik SY, Tang Y, Eisner
W and Spurney RF: Calcineurin (CN) activation promotes apoptosis of
glomerular podocytes both in vitro and in vivo. Mol Endocrinol.
25:1376–1386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schlöndorff J, Del Camino D, Carrasquillo
R, Lacey V and Pollak MR: TRPC6 mutations associated with focal
segmental glomerulosclerosis cause constitutive activation of
NFAT-dependent transcription. Am J Physiol Cell Physiol.
296:C558–C569. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nijenhuis T, Sloan AJ, Hoenderop JG,
Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer
RA, Möller CC, et al: Angiotensin II contributes to podocyte injury
by increasing TRPC6 expression via an NFAT-mediated positive
feedback signaling pathway. Am J Pathol. 179:1719–1732. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu QT, Qi LW, Li P, Yi L, Zhao J and Bi Z:
Determination of seventeen main flavonoids and saponins in the
medicinal plant Huang-qi (Radix astragali) by HPLC-DAD-ELSD. J Sep
Sci. 30:1292–1299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu LH, Xie XJ and Zhang BQ: Astragaloside
IV improves homocysteine-induced acute phase endothelial
dysfunction via antioxidation. Biol Pharm Bull. 33:641–646. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao J, Yang P, Li F, Tao L, Ding H, Rui
Y, Cao Z and Zhang W: Therapeutic effects of astragaloside IV on
myocardial injuries: Multi-target identification and network
analysis. PLoS One. 7:e449382012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gui D, Huang J, Guo Y, Chen J, Chen Y,
Xiao W, Liu X and Wang N: Astragaloside IV ameliorates renal injury
in streptozotocin-induced diabetic rats through inhibiting
NF-κB-mediated inflammatory genes expression. Cytokine. 61:970–977.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, Gui D, Chen Y, Mou L, Liu Y and
Huang J: Astragaloside IV improves high glucose-induced podocyte
adhesion dysfunction via alpha3beta1 integrin upregulation and
integrin-linked kinase inhibition. Biochem Pharmacol. 76:796–804.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gui D, Guo Y, Wang F, Liu W, Chen J, Chen
Y, Huang J and Wang N: Astragaloside IV, a novel antioxidant,
prevents glucose-induced podocyte apoptosis in vitro and in vivo.
PLoS One. 7:e398242012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
36
|
Reiser J, Polu KR, Möller CC, Kenlan P,
Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C,
et al: TRPC6 is a glomerular slit diaphragm-associated channel
required for normal renal function. Nat Genet. 37:739–744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mundel P, Reiser J, Borja AZM, Pavenstädt
H, Davidson GR, Kriz W and Zeller R: Rearrangements of the
cytoskeleton and cell contacts induce process formation during
differentiation of conditionally immortalized mouse podocyte cell
lines. Exp Cell Res. 236:248–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang
S, Du P, Zhang X and Yi F: NADPH oxidase-derived ROS contributes to
upregulation of TRPC6 expression in puromycin
aminonucleoside-induced podocyte injury. Cell Physiol Biochem.
24:619–626. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang H, Ding J, Fan Q and Liu S: TRPC6
upregulation in Ang II-induced podocyte apoptosis might result from
ERK activation and NF-κB translocation. Exp Biol Med (Maywood).
234:1029–1036. 2009. View Article : Google Scholar
|
|
40
|
Wu H, Peisley A, Graef IA and Crabtree GR:
NFAT signaling and the invention of vertebrates. Trends Cell Biol.
17:251–260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Crabtree GR: Calcium, calcineurin, and the
control of transcription. J Biol Chem. 276:2313–2316. 2001.
View Article : Google Scholar
|
|
42
|
Li R, Zhang L, Shi W, Zhang B, Liang X,
Liu S and Wang W: NFAT2 mediates high glucose-induced glomerular
podocyte apoptosis through increased Bax expression. Exp Cell Res.
319:992–1000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Reed JC: Proapoptotic multidomain
Bcl-2/Bax-family proteins: Mechanisms, physiological roles, and
therapeutic opportunities. Cell Death Differ. 13:1378–1386. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kriz W, Gretz N and Lemley KV: Progression
of glomerular diseases: Is the podocyte the culprit? Kidney Int.
54:687–697. 1998. View Article : Google Scholar : PubMed/NCBI
|
